9th Jun 2015 14:19
LONDON (Alliance News) - Oxford BioMedica PLC said Non-Executive Director Daniel Soland bought 500,000 shares at a price of 9.45 pence per share Tuesday.
Following this transaction, Soland holds 14 million shares, which represents a 0.05% stake in the firm.
Shares in the gene and cell therapy group were down 2.2% at 9.38p Tuesday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica